ES2155620T3 - Estabilizacion de plasmidos. - Google Patents

Estabilizacion de plasmidos.

Info

Publication number
ES2155620T3
ES2155620T3 ES96929443T ES96929443T ES2155620T3 ES 2155620 T3 ES2155620 T3 ES 2155620T3 ES 96929443 T ES96929443 T ES 96929443T ES 96929443 T ES96929443 T ES 96929443T ES 2155620 T3 ES2155620 T3 ES 2155620T3
Authority
ES
Spain
Prior art keywords
repressor
plasmid
gene
expressed
essential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96929443T
Other languages
English (en)
Inventor
David John Sherratt
Steven Geraint Williams
Julian Alexis John Hanak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cobra Therapeutics Ltd
Original Assignee
Cobra Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobra Therapeutics Ltd filed Critical Cobra Therapeutics Ltd
Application granted granted Critical
Publication of ES2155620T3 publication Critical patent/ES2155620T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Abstract

SE DESCRIBE UN SISTEMA QUE UTILIZA UN METODO NOVEDOSO DE TITULACION DEL REPRESOR PARA EL MANTENIMIENTO DE UN PLASMIDO UTIL EN TERAPIA GENICA Y EN LA PRODUCCION DE UNA PROTEINA RECOMBINANTE. EL SISTEMA UTILIZA UNA CELULA HUESPED TRANSFORMADA QUE CONTIENE UN PLASMIDO QUE INCLUYE UN OPERADOR SUSCEPTIBLE DE UNION POR UN REPRESOR EXPRESADO EN TRANS, UN PRIMER GEN CROMOSOMICO QUE CODIFICA EL REPRESOR, Y UN SEGUNDO GEN CROMOSOMICO ASOCIADO FUNCIONALMENTE A UN OPERADOR Y ESENCIAL PARA EL CRECIMIENTO CELULAR, EN EL QUE EL PLASMIDO ESTA PRESENTE EN LA CELULA EN CANTIDAD SUFICIENTE PARA TITULAR EL REPRESOR DE FORMA QUE SE EXPRESE EL GEN ESENCIAL, PERMITIENDO ASI EL CRECIMIENTO DE LA CELULA.
ES96929443T 1995-09-08 1996-09-06 Estabilizacion de plasmidos. Expired - Lifetime ES2155620T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518395.0A GB9518395D0 (en) 1995-09-08 1995-09-08 Plasmid stabilization

Publications (1)

Publication Number Publication Date
ES2155620T3 true ES2155620T3 (es) 2001-05-16

Family

ID=10780420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96929443T Expired - Lifetime ES2155620T3 (es) 1995-09-08 1996-09-06 Estabilizacion de plasmidos.

Country Status (14)

Country Link
US (1) US5972708A (es)
EP (1) EP0851932B1 (es)
JP (1) JP3416888B2 (es)
KR (1) KR100356581B1 (es)
AT (1) ATE199168T1 (es)
AU (1) AU710494B2 (es)
CA (1) CA2231784C (es)
DE (1) DE69611794T2 (es)
DK (1) DK0851932T3 (es)
ES (1) ES2155620T3 (es)
GB (1) GB9518395D0 (es)
GR (1) GR3035806T3 (es)
PT (1) PT851932E (es)
WO (1) WO1997009435A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763270A (en) * 1995-06-07 1998-06-09 Genemedicine, Inc. Plasmid for delivery of nucleic acids to cells and methods of use
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
WO2001034810A2 (en) 1999-11-09 2001-05-17 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation
AU2277401A (en) * 1999-12-23 2001-07-09 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation of e. coli
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
US20030180953A1 (en) * 2000-12-29 2003-09-25 Elitra Pharmaceuticals, Inc. Gene disruption methodologies for drug target discovery
US20030119013A1 (en) * 2001-04-23 2003-06-26 Bo Jiang Identification of essential genes of Aspergillus fumigatus and methods of use
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US20030170694A1 (en) * 2001-12-21 2003-09-11 Daniel Wall Stabilized nucleic acids in gene and drug discovery and methods of use
GB0211459D0 (en) * 2002-05-18 2002-06-26 Cobra Therapeutics Ltd Plasmid stabilisation in vivo
WO2005042750A1 (en) * 2003-10-31 2005-05-12 Novozymes A/S Method for stable gene-amplification in a bacterial host cell
GB0327056D0 (en) * 2003-11-20 2003-12-24 Cobra Biolog Ltd Plasmid maintenance
CA2619989C (en) * 2005-08-23 2014-06-17 National Research Council Of Canada Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria
WO2009073551A2 (en) * 2007-11-30 2009-06-11 Scarab Genomics Llc Lac expression system
EP2353607A1 (en) 2010-02-04 2011-08-10 BioAlliance Pharma Use of disintegrin domain of an adamalysin for the treatment of psoriasis
EP3205356A1 (en) 2016-02-10 2017-08-16 Onkoloski Institut Ljubljana Plasmid expression vector encoding human interleukin 12 under transcriptional control of p21 promoter and without antibiotic resistance for cancer gene therapy and other uses thereof
DK3534936T3 (da) * 2016-11-01 2020-11-02 Novo Nordisk As Tolerogen dna-vaccine
WO2019226650A1 (en) 2018-05-23 2019-11-28 Modernatx, Inc. Delivery of dna
AU2021285812A1 (en) 2020-06-01 2023-01-05 Modernatx, Inc. Phenylalanine hydroxylase variants and uses thereof
EP4337177A1 (en) 2021-05-11 2024-03-20 Modernatx, Inc. Non-viral delivery of dna for prolonged polypeptide expression in vivo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
GB8308236D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Dna vectors
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
GB9215550D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5763270A (en) * 1995-06-07 1998-06-09 Genemedicine, Inc. Plasmid for delivery of nucleic acids to cells and methods of use

Also Published As

Publication number Publication date
JPH11511985A (ja) 1999-10-19
KR19990044525A (ko) 1999-06-25
WO1997009435A1 (en) 1997-03-13
DE69611794T2 (de) 2001-08-02
EP0851932A1 (en) 1998-07-08
GR3035806T3 (en) 2001-07-31
EP0851932B1 (en) 2001-02-14
US5972708A (en) 1999-10-26
DE69611794D1 (de) 2001-03-22
KR100356581B1 (ko) 2003-04-10
CA2231784A1 (en) 1997-03-13
CA2231784C (en) 2010-06-22
ATE199168T1 (de) 2001-02-15
DK0851932T3 (da) 2001-06-18
AU710494B2 (en) 1999-09-23
AU6885596A (en) 1997-03-27
PT851932E (pt) 2001-07-31
GB9518395D0 (en) 1995-11-08
JP3416888B2 (ja) 2003-06-16

Similar Documents

Publication Publication Date Title
ES2155620T3 (es) Estabilizacion de plasmidos.
ES8603955A1 (es) Preparacion de igf y egf de humano por tecnologia de adn recombinante
ES8306325A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
DE69329202D1 (de) Methoden der erhöhung der sekretion von überexpremierten proteinen
ES481362A1 (es) Un metodo de preparar una proteina seleccionada o una parte de la misma.
ES8304200A1 (es) "un procedimiento para formar dna doble filamentado".
AU551251B2 (en) Recombinant dna; chymosin production
ZA887773B (en) Interleukin-7
AU7155296A (en) Interleukin-19
AU577810B2 (en) Cloning the gene for rabbit tumor necrosis factor polypeptide
NO892029L (no) Fremgangsmaate ved spesifikk genetisk manipulering av mikroorganisme.
ES8506194A1 (es) Polipeptido de interferon- humano
BR8406680A (pt) Processo para preparacao de um plasmidio,processo para expressao eficiente de proteinas heterologas,para preparacao de um transformante e processo para producao de prorrenina
AU2430588A (en) Mutant acidic fibroblast growth factor
EP0187630A3 (en) Cloned streptomyces beta-galactosidase gene
ES8504248A1 (es) Procedimiento para la fabricacion de un plasmido recombinante que contiene un aminoacido
EP0300425A3 (de) Verfahren zur Herstellung von Proteinen in löslicher Form
WO1993018151A1 (fr) Element transposable originaire d'une bacterie du genre brevibacterium
ES8800361A1 (es) Un metodo para producir un interferon-gamma
JPS6485094A (en) Novel physiologically active polypeptide
ES8704513A1 (es) Un metodo para producir una proteina heterologa
AU2371188A (en) Cloning afl ii restriction endonuclease and methylase from anabaena flos-aquae
ES8800350A1 (es) Procedimiento para preparar una cepa microbiana transformada mediante un plasmido recombinante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 851932

Country of ref document: ES